Congress returns with budget reconciliation at the top of the to-do list. Key House authorizing committees are slated to kick off markups on their respective budget reconciliation instructions that...
Big Wins for Rare Liver Disease: New Codes, Drug Approvals, and Global Advocacy – Pediatric and Rare Liver Diseases News New ICD-10 Codes for Fontan-Associated Conditions The...
Treatment Advances & Prevention ResearchGlobal Liver Institute brings you key updates in liver cancer research and treatment. We highlight the final results from a Phase II combination therapy...
Liver Health Insights, Events, and a Global ChallengeA Note from the Director, Dr. Sharon H. Jaycox I recently conducted a workshop titled: Advanced Strategies: Navigating Credible Research and...
GLI Statement on the CMS 2026 Medicare Advantage and Part D Final Rule and Anti-Obesity Medication Coverage WASHINGTON, DC – On Friday, April 4, 2025, the U.S. Centers for Medicare and Medicaid...
Administration focuses on health program consolidations and terminates more federal employees, leaving some key health programs without staff. Medicaid cuts are still under consideration in Congress...
Advances in Treatment, Diagnosis, and Care Liver Disease Prevention Through NutritionJoin us on Monday, April 21, 2025, at 3:00 PM PST | 6:00 PM EST for GLI’s Liver Cancer Lessons: Liver...
Meet Our New Fatty Liver Disease Program Director!Meet the Director Global Liver Institute is excited to announce the appointment of Dr. Sharon Jaycox as the new Fatty Liver Disease Program...
Rare Science, Real Impact: A Student’s Perspective – Pediatric and Rare Liver Diseases News Student Feature: My Experience Beyond February’s Rare Science Fairs Project MiKayla Chapman,...
Proactive Protection of the Liver Health of Asian AmericansHepatitis B is a liver infection caused by the hepatitis B virus (HBV) that can cause long-term (chronic) disease. Chronic hepatitis B can...
Recent News
GLI Supports the Reintroduction of the Treat and Reduce Obesity Act(Washington, D.C., June 9, 2025) – Global Liver Institute (GLI) applauds the reintroduction of the bipartisan Treat and Reduce Obesity Act, which was recently introduced by Senators Bill Cassidy (R-LA)...
Hep C Elimination Bill - Statement of Support Global Liver Institute (GLI) proudly supports legislation (S. 1941) introduced by Senators Bill Cassidy (R-LA) and Chris Van Hollen (D-MD) aiming to implement a nationwide elimination program for the hepatitis C virus...
Liver Health Insights, Events, and a Global ChallengeA Note from the Director, Dr. Sharon H. Jaycox Reflecting on EASL Congress 2025 – A Call to Action for Liver Health Equity Attending EASL 2025 in Amsterdam was an eye-opening and inspiring experience. I had the...
Addressing Liver Cancer Disparities & Advancing TreatmentGlobal Liver Institute brings you key updates in liver cancer care and health equity. This edition features a 5-year update on the Financial Toxicity Tumor Board Model, highlighting how multidisciplinary...
First Ever Rare Liver Disease Patient Cured with Personalized Gene Therapy Treatment Collaboration and Ideas Driven from Conversations at EASL Congress, Amsterdam Kristin Hatcher, Director of our Pediatric and Rare Liver Diseases Program, joined global...
